Skip to main content

Nacalai to Distribute TriLink's Nucleic Acid Products in Asia

Premium

TriLink BioTechnologies this week announced that Nacalai, a manufacturing and marketing company based in San Diego, Calif., will distribute its modified nucleic acid products in Japan, Singapore, South Korea, and Taiwan.

TriLink manufactures custom oligonucleotides, modified nucleoside triphosphates, and CleanAmp PCR products for the diagnostic and original equipment manufacturer markets.

The agreement follows another distribution deal that TriLink signed last week that gave French distributor Tebu-Bio the rights to market its CleanAmp products for hot-start PCR in Europe [PCR Insider 01-14-2010].

Filed under

The Scan

Rise of B.1.617.2 in the UK

According to the Guardian, UK officials expect the B.1.617.2 variant to soon be the dominant version of SARS-CoV-2 there.

Anne Schuchat to Retire

Anne Schuchat is retiring after more than 30 years at the US Centers for Disease Control and Prevention, Politico reports.

US to Share More Vaccines

CNN reports that the US will share 20 million doses of the Moderna, Pfizer, and Johnson & Johnson SARS-CoV-2 vaccines with other countries.

PNAS Papers on Gene Therapy Platform, Aspergillus Metabolome, Undernutrition Model Microbiome

In PNAS this week: approach to deliver protein-based treatments to cells, pan-secondary metabolome of Aspergillus, and more.